Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LANSOPRAZOLE Cause Urinary tract infection? 260 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 260 reports of Urinary tract infection have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 0.4% of all adverse event reports for LANSOPRAZOLE.

260
Reports of Urinary tract infection with LANSOPRAZOLE
0.4%
of all LANSOPRAZOLE reports
33
Deaths
106
Hospitalizations

How Dangerous Is Urinary tract infection From LANSOPRAZOLE?

Of the 260 reports, 33 (12.7%) resulted in death, 106 (40.8%) required hospitalization, and 3 (1.2%) were considered life-threatening.

Is Urinary tract infection Listed in the Official Label?

Yes, Urinary tract infection is listed as a known adverse reaction in the official FDA drug label for LANSOPRAZOLE.

What Other Side Effects Does LANSOPRAZOLE Cause?

Chronic kidney disease (32,517) Acute kidney injury (16,359) Renal failure (12,509) End stage renal disease (9,734) Renal injury (9,383) Tubulointerstitial nephritis (3,860) Death (2,517) Gastrooesophageal reflux disease (2,482) Off label use (2,183) Nephrogenic anaemia (2,162)

What Other Drugs Cause Urinary tract infection?

ADALIMUMAB (6,375) LENALIDOMIDE (4,247) ETANERCEPT (3,915) OCRELIZUMAB (3,618) TOFACITINIB (3,179) METHOTREXATE (2,960) DALFAMPRIDINE (2,757) RITUXIMAB (2,579) CARBIDOPA\LEVODOPA (2,151) ABATACEPT (2,110)

Which LANSOPRAZOLE Alternatives Have Lower Urinary tract infection Risk?

LANSOPRAZOLE vs LANTHANUM LANSOPRAZOLE vs LANTUS LANSOPRAZOLE vs LANTUS SOLOSTAR LANSOPRAZOLE vs LAPATINIB LANSOPRAZOLE vs LAPATINIB DITOSYLATE

Related Pages

LANSOPRAZOLE Full Profile All Urinary tract infection Reports All Drugs Causing Urinary tract infection LANSOPRAZOLE Demographics